TLR4 and infection: HIV-1BaL, a laboratory adapted CCR5-tropic HIV, infection rendered KCs more sensitive to LPS treatment through an increase in CD14 and TLR4 expression on the cell surface, resulting in increased secretion of TNF-α and IL-6, which was blocked by a small molecule TLR4 inhibitor.